Comparison the efficacy of four different alpha blockers in the treatment of benign prostatic hyperplasia
Yazarlar (6)
Prof. Dr. Doğan ATILĞAN Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Dr. Öğr. Üyesi Adem Yaşar Tip Fakültesi, Türkiye
Fikret Erdemir Tip Fakültesi, Türkiye
Bekir Süha Parlaktaş Tip Fakültesi, Türkiye
Nihat Uluocak Tip Fakültesi, Türkiye
Fatih Firat Tip Fakültesi, Türkiye
| Makale Türü | Özgün Makale (SCOPUS dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Journal of Clinical and Analytical Medicine | ||
| Dergi ISSN | 1309-0720 | ||
| Makale Dili | İngilizce | Basım Tarihi | 05-2011 |
| Cilt / Sayı / Sayfa | 2 / 2 / 27–31 | DOI | 10.4328/JCAM.259 |
| Makale Linki | http://www.scopus.com/inward/record.url?eid=2-s2.0-79952260796&partnerID=MN8TOARS | ||
| UAK Araştırma Alanları |
Sağlık Bilimleri
|
||
| Özet |
| Aim Benign prostatic hyperplasia (BPH) also known as nodular hyperplasia, benign enlargement of the prostate refers to the increase in size of the prostate in middle aged and elderly men. Although four different types of specific alpha blocker have been used in the treatment of BPH it remains controversial that which alpha adrenergic blocker is effective than others. The aim of this study is to compare the efficacy of 4 different alpha blockers agents on the treatment of BPH. Material and Methods Between June 2005 and December 2008 a total of 135 consecutive patients with diagnosed of BPH were evaluated in our clinic. Patients were randomized into four groups according to alpha blocker types as fallows: group I, doxazosin 4 mg; group II, tamsulosin 0.4 mg; group III, terazosin 5 mg; and group IV, alfuzosin 10 mg. All patients were followed up with International Prostatic Symptom Score (IPSS), maximal urinary … |
| Anahtar Kelimeler |
| Alpha Blockers | Benign Prostatic Hyperplasia | Efficacy | Treatment |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Web of Science | 12 |
| Scopus | 5 |
| Google Scholar | 10 |